Global Laboratory Automation Market Analysis & Outlook 2030

  • Product Code:
    RP-ID-10352166
  • Published Date:
    21 Oct 2022
  • Region:
    Global
  • Category:
    Automotive & Transportation
  • Publisher:
    Pub-ID-54

Impact Analysis on the Growth of Market

Inflation and Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

..

..

The Research Report is Updated with 2022 Base Year, 2023 Estimated year and Forecast till 2035 with Market Insights.


With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2022 as base year, 2023 as estimated year and forecast to 2035. This will have market drivers, recovery rate in the market, insights and competitive analysis.



Market Overview:

Translate Report

The global laboratory automation market is estimated to be USD 5 billion in 2021, and it is expected to expand at a compound annual growth rate (CAGR) of 9% from 2022 to 2030. Laboratory automation uses technology to replace or simplify manual processes and equipment for processes. The degree of automation depends on the workflow of the laboratory. In academic and research institutions, automated instruments are widely used more and more frequently to increase their productivity and reduce the time spent on various tedious tasks. In addition, it is expected that the use of automated instruments in drug discovery departments of pharmaceutical companies will extensively automate their research phases, thereby driving market growth.

 The increasing benefits of laboratory automation are expected to be one of the main factors driving market growth in the near future. For clinical laboratories, the paradigm shift from fully manual intervention to laboratory automation has several advantages. Some important benefits include increased productivity, reliable results, safe working conditions, and substantial savings in testing time, space, and costs. Laboratory automation allows laboratory equipment to be easily used for monotonous tasks, such as labeling tubes and sample inspections. It also helps to reduce and minimize the manual labor caused by manual tasks, reduce costs and save laboratory space. Therefore, some of the advantages provided by automation systems are expected to encourage small and large laboratories to adopt these workstations in the near future. Increasing demand for miniaturization is another factor that is expected to significantly affect market growth in the near future. One of the main reasons for implementing automation systems and workstations in clinical laboratories is to promote the miniaturization of research processes in order to develop solutions for various complex laboratory automation tasks in biotechnology, microbiology, chemistry, and clinical applications. In addition, the miniaturization of these processes facilitates cell expansion, monitoring and culture, and increases the response time of the bedside environment. The growth in the number of laboratory automation applications is expected to drive market growth in the near future. In recent laboratories, automation has discovered some applications that have revolutionized laboratory processes, which are usually carried out by manual intervention. Some of these include applications such as automated chemistry, synthetic biology, cell line development, genomics, cell analysis, and drug discovery. Therefore, it is expected that the increase in the number of clinical applications of automated laboratory instruments will increase the adoption of laboratory automation during the forecast period.

Process Insights:
Due to the high adoption of continuous flow in laboratories to provide high-quality services, the continuous flow segment dominates the entire market and has the highest revenue share in 2020 at 60%. In addition, continuous flow analysis is a mature technology, and it is also an ideal choice when a large number of samples need to be analyzed to reduce the chemical composition. According to the different processes, the market is divided into continuous processes and discrete processes. The discrete processing part is expected to grow at a significant rate during the forecast period. This can be attributed to several advantages of discrete processing over streaming, which are expected to support its adoption during the forecast period. In discrete processing, each sample is assigned a discrete space, so the analysis of samples is improved in this process. Therefore, compared with continuous flow processing, the excess reagent used for flow is not wasted. Due to its various advantages over continuous processing, this market segment is expected to achieve significant growth during the forecast period.

 End-use insights:
The clinical chemistry analysis department dominates the market, with the largest revenue share in 2020 at 25%. This high share is attributable to technological advances, the increase in automation systems provided by market participants, and the growth in the use of automation systems. The advantages of automation systems lie in their advantages, such as reducing pollution risks and eliminating human error, among other advantages. According to the end use, the market is divided into clinical chemistry, photometric and fluorometric analysis, immunoassay analysis and electrolyte analysis. Significant technological advances have been made in the automation of immunoassays.

 By hands-free and automated processing of several small batches of immunoassays in the research laboratory, potential end users have a variety of immunoassay analysis options. Another end-use segment includes the use of automated systems in forensic laboratories and biobanks. The Dutch Institute of Forensic Medicine is a forensic laboratory that uses automated workflows to ensure that the processes performed by professionals comply with strict design rules. The laboratory uses the automation system provided by Hamilton. The company also provides automated systems to protect and store biological sample library samples during processing to ensure better quality of diagnostic results.

Regional insight:
North America dominates the laboratory automation market, with the largest revenue share in 2020 at 35%, and it is expected to maintain this position during the forecast period. The growth is attributed to the existence of a well-developed healthcare infrastructure, which has led to an increase in the adoption of laboratory automation systems in the region. In addition, the local presence of major players in the region and the supported reimbursement framework also promote the penetration of new solutions in the market. In the Asia-Pacific region, the market is expected to show an exponential compound annual growth rate of 9.9% during the forecast period, which can be attributed to the growing demand for laboratory automation in emerging economies such as China and India.

The lucrative growth recorded in the region is also considered to be the result of increasing initiatives by regional and international players to introduce new laboratory automation solutions in these potential markets. Have a positive impact on the MEA market. In addition, the increase in the number of government initiatives to improve the healthcare infrastructure in Saudi Arabia and the United Arab Emirates is also expected to drive the demand for laboratory automation solutions. To promote market growth. In May 2017, Qiagen and Japanese in vitro diagnostic company Maccura Biotechnology Co., Ltd. established a joint venture company.

The joint venture is called MAQGEN and aims to accelerate the localization, commercialization and development of the GeneReader NGS system in China Growing clinical research and clinical market. Therefore, the increase in the adoption rate of such measures is expected to promote the adoption of global automated instruments in the near future. In January 2019, Roche launched the cobas pro integrated solution in all countries that accepted the brand.

The product restores the standards of maintenance, efficiency and reliability by improving patient satisfaction and reducing healthcare costs. Therefore, it is expected that the increase in the number of initiatives taken by large companies will increase their geographic influence in the near future. Some of the major players in the laboratory automation market include: Qiagen NV PerkinElmer Inc. Thermo Fisher Scientific, Inc. Siemens Healthineers Danaher Corporation Agilent Technologies, Inc. Bio Tek Instruments, Inc. Eppendorf AG Hudson Robotics Aurora Biomed Inc. BMG LABTECH GMBH Tecan Group Hamilton company.

 Market segments covered by the report:
The report forecasts global, regional and national revenue growth, and analyzes the latest industry trends in each sub-segment from 2022 to 2030. For the purpose of this research, Kenneth Research will report on the global laboratory automation market based on process, automation type, end use, and region: Process Outlook (Revenue, USD Million, 2022 to 2030) Continuous flow is processed in order of process workflow Parallel processing components, consumable equipment, discrete processing methods, centrifugal processing, discrete processing, random access, discrete workflow components, analysis of consumables, independent analysis, automated type perspective (revenue, million dollars, 2022 to 2030) Fully automated system gradually pre-analyzes centrifugal sample preparation, sample classification and transportation mechanism Liquid handling sample storage sample analysis modular automated system gradually collects, identifies and marks sample transportation mechanism sample preparation sample loading and inhalation reagent processing and storage sample analysis and measurement end-use prospects (revenue, millions of dollars), 2022 to 2030) Clinical Chemical analysis, photometry and fluorescence method, immunoassay, electrolyte analysis, other end uses

 


Geography Analysis:


The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

  • North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys  & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook

.

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports

-->